There was big news today for Kyverna Therapeutics, Inc. ( KYTX ) as they announced some very positive top line data on Miv-cel this morning. As a result, shares are up 35% pre-market. Because of the strengthI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigo ...